fura-2 has been researched along with Granulocytic Leukemia, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heise, N; Henke, G; Huber, SM; Koka, S; Lang, F; Misovic, M; Palme, D; Rudner, J; Salih, HR | 1 |
Anderson, KM; Bonomi, P; Buyn, T; Dudeja, P; Harris, JE; Meng, J; Ou, D; Sawlani, D; Seed, T | 1 |
2 other study(ies) available for fura-2 and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Non-selective cation channel-mediated Ca2+-entry and activation of Ca2+/calmodulin-dependent kinase II contribute to G2/M cell cycle arrest and survival of irradiated leukemia cells.
Topics: Calcium; Calcium Channels; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Division; Chelating Agents; Egtazic Acid; Fura-2; G2 Phase; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Patch-Clamp Techniques; Protein Kinase Inhibitors; Radiation Tolerance; Radiation, Ionizing; TRPV Cation Channels | 2010 |
A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell death.
Topics: Amiloride; Apoptosis; Calcium; Cell Survival; DNA; Fluoresceins; Fura-2; Humans; Hydrogen-Ion Concentration; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Male; Prostate; Trypsin; Tumor Cells, Cultured | 1997 |